Urinalysis Market by Product (Instruments and Consumables), Application (UTIs, Kidney Disease, Liver Disease, Diabetes, Hypertension, and Others), End-user (Hospitals, Clinical Laboratories, Home Healthcare, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028

Global Urinalysis Market Analysis

According to the urinalysis market forecast, the global market size is estimated to cross $4,776.9 million by 2028, growing from $2,944.0 million in 2020, at a CAGR of 6.3%.

Market Synopsis

Rising geriatric population along with the significant rise in age-related disorders to drive the global urinalysis market.

However, a high investment cost may obstruct the growth of the global urinalysis market

According to the regional analysis of the urinalysis market, the Asia-Pacific market is anticipated to surge at a CAGR of 7.1%, by registering a revenue of $902.8 million, during the forecast period.

Urinalysis Overview

The urinalysis is an examination of urine to detect and manage a broad range of disorders, including kidney disease, diabetes, and urinary tract infections (UTIs). A urinalysis primarily involves checking the concentration content and appearance of the urine. Other terminologies for it are urine analysis, urine test, and UA.

COVID-19 Impact on Urinalysis Market

In response to the Covid-19 pandemic, business sector namely transportation, petroleum, retail, and tourism industry have been forced to reconsider their business models and policies. Furthermore, global urinalysis market has also witnessed declined growth, throughout the pandemic period mainly because of disruption in the supply chain and temporary halt of production operations. Also, the communal transmission of COVID-19 severely impacted the sales of majority of the firms.

On the other hand, key players operating in the urinalysis market are coming up with effective collaborations. For instance, in January 2020, Sysmex Corporation, leading Japanese healthcare player, announced the official agreement to invest in Astrego Diagnostics AB, Sweden-based rapidly growing in-vitro diagnostic company. As per this agreement, Sysmex aims to develop and market a ‘rapid drug susceptibility test^1’, an innovative urinalysis solution. Such notable investments may further create significant opportunities for the investors, post COVID-19 outbreak.

Rising Geriatric Population along with the Significant Rise in Age-related Disorders to Drive the Global Urinalysis Market

The dramatically growing geriatric population across the globe will significantly influence the global urinalysis market growth, during the forecast period. As per information published by World Health Organization (WHO), a specialized agency of the United Nations (UN) responsible for international public health, the number of people aged 65 or older is expected to surge from 524 million in 2010 to almost 1.5 billion by the end of 2050. Owing to such fast growth in the senior population, the prevalence of age-related diseases and conditions namely liver & kidney diseases and diabetes are anticipated to increase notably. The diagnosis and treatment of above-stated diseases are responsible for the rising number of prescriptions for tests like albumin, creatinine, ketones, glucose, and others. These tests are performed through urine analysis, thereby, it is predicted to have a significant impact on the urinalysis market, during the forecasted period.

To know more about global urinalysis market drivers, get in touch with our analysts here.

A High Investment Cost may Obstruct the Growth of the Global Urinalysis Market

Requirement of high investment in the development of urinalysis product manufacturing plant may restrict the global urinalysis market growth, in the analysis period. Moreover, implementation of excise tax by the U.S. government combined with stringent regulatory policies may hamper the growth of the global urinalysis market.

Extensive Increase in the Burden of Liver Diseases Particularly in the LAMEA Region to Create Enormous Opportunities for the Global Market in the Future

The prevalence of kidney and liver diseases remains high worldwide particularly in the Latin American and Middle East countries. The death rate caused by liver disease in Egypt is by far the highest across the globe, followed by other African countries. For example, as per data published in 2018 by World life expectancy, the largest global health and life expectancy databases, liver disease death rate per 100,000 patients in Egypt, Nigeria, Ivory Coast, and São Tomé is 116.0, 64.4, 62.1, and 60.7 respectively. Hence, the demand for urinalysis procedure and consumables like urine test strips is expected to grow exponentially, which will further drive the global urinalysis market, in the analysis period

To know more about global urinalysis market opportunities, get in touch with our analysts here.

Source: Research Dive Analysis

The instruments sub-segment is expected to have the lucrative growth in the global market and register a revenue of $1,528.4 million by 2028.
Significantly growing investments in the field of medical devices, mainly owing to enormous benefits provided by integrated urine analyzers and automated urine analyzers are creating positive impact on the instruments’ sub-segment. In addition, increase in healthcare expenditure, surge in the public awareness, and growing incidence of UTIs, diabetes, and kidney disease are some important factors projected to continue to augment market growth.

Moreover, prominent players of the market are coming up with novel innovations in order to strengthen their presence worldwide. For example, in August 2018, Beckman Coulter, a Danaher Corporation company that develops medical diagnostics products, and U.S. Arkray, notable urinalysis player, announced a strategic partnership and the official release of the iQ Urinalysis Workcell. Such company inventions are further expected to create enormous opportunities, across the globe.  

The consumables sub-segment is expected to have the major share in the global market and register a revenue of $3,252.4 million by 2028. The frequent purchase of products including dipsticks, reagents, and disposable owing to their recurrent usage bolsters the market growth of this sub-segment. Furthermore, key factors including surging developments in multiple urine test kits and test strips along with the constant demand for lower-cost and user-friendly consumables by end-users are also fueling the market growth.

Source: Research Dive Analysis

The UTIs sub-segment of the global urinalysis market is estimated to grow at the most notable CAGR and surpass $1,933.0 million by 2028, with a rise from $1,155.9 million in 2020.
The surging need for early diagnosis of urinary tract infections (UTIs) conditions, along with increasing awareness regarding conducting regular health check-ups is one of the crucial elements contributing to the significant share of this sub-segment. Furthermore, novel product launches are also fueling the sub-segment’s growth. For instance, in November 2019, Scanwell Health, at-home medical testing platform provider, announced the official launch of smartphone-based tests for UTIs. Through Scanwells’ collaboration with Lemonaid Health, a notable telemedicine provider for physicians, patient can get diagnosed utilizing the Scanwell app along with receiving a course of treatment and consultation from their home. Such inventions are further expected to drive the sub-segments’ growth, in the analysis period.

Source: Research Dive Analysis

The hospitals sub-segment of the global urinalysis market is estimated to have largest share and surpass $2,640.3 million by 2028, with a rise from $1,659.7 million in 2020.
The excellent health coverage and ease of accessibility of hospital-based services from multiple private and group insurance plans are several key factors contributing to the maximum share of the hospitals sub-segment. Also, modernization of healthcare facilities along with government’s favorable schemes are accelerating the growth of hospitals sub-segment.

The home healthcare sub-segment of the global urinalysis market is estimated to grow at the most notable CAGR and surpass $684.4 million by 2028, with a rise from $389.4 million in 2020. The increasing trend of automation being utilized in the urinalysis is expected to provide an ancillary force for self-test urinalysis devices. Moreover, in September 2018, inui Health, Silicon Valley based consumer medical diagnostics company, announced that it had received FDA grant for its smartphone-based home urine testing platform that can perform 5 other tests. Such company developments are also further expected to drive the sub-segments’ growth.

Source: Research Dive Analysis

The Market for Urinalysis in Asia-Pacific to be the Most Lucrative

Asia-Pacific urinalysis market accounted $524.0 million in 2020 and is expected to register a revenue of $902.8 million by 2028.
The extensively increasing need for advanced and innovative liver and kidney diseases diagnostics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of UTIs & hypertension, lack of expertise, and the poor healthcare infrastructure in the region. In addition to this, aging population combined with technological innovations in the urinalysis industry is further expected to boost the demand for urinalysis procedures, in the region.

The North America Urinalysis Market to be the Most Dominant

North America is expected to hold the largest urinalysis market share throughout 2021–2028. North America urinalysis market accounted $1,578.0 million in 2020 and is expected to register a revenue of $2,541.3 million by 2028. The growth of North America urinalysis market is mainly driven by the implementation of favorable government initiatives, growing geriatric population, the availability of technologically advanced instruments, improved healthcare infrastructure, and rising healthcare expenditure.

Competitive Scenario in the Global Urinalysis Market

Treatment type launches and mergers & acquisitions are common strategies followed by major market players.

Source: Research Dive Analysis

Some of the leading urinalysis market players are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., Abbott Laboratories, Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and ARKRAY, Inc.

Porter’s Five Forces Analysis for the Global Urinalysis Market:

• Bargaining Power of Suppliers: The suppliers operating in the global urinalysis are high in number and are much larger & more globalized. So, there will be less threat from the supplier.
  Thus, the bargaining power of the supplier is low.      
• Bargaining Power of Buyers: Buyers demand effective urinalysis procedures at lower cost. This has increased the pressure on the multiple medical devices manufacturers to offer the instruments in a cost-effective way. Thus, many suppliers have started offering best yet cost –effective urinalysis. This gives the buyers the option to freely choose urinalysis instruments that best fits their preference.
  Thus, the bargaining power of the buyers is high.
• Threat of New Entrants: The companies entering the global urinalysis market are adopting technological innovations to attract customers. Also, these companies are implementing various effective strategies and there is government support in some countries.
  Thus, threat of the new entrants is high.
• Threat of Substitutes: There is no alternative treatment type available. 
  Thus, the threat of substitutes is low.
• Competitive Rivalry in the Market: The competitive rivalry among the industry leaders is rather intense, especially between the global players including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Cardinal Health, Inc. These companies are launching their value-added services in the international market and strengthening the footprint worldwide.
  Therefore, the competitive rivalry in the market is high.